Armando Giuliano

Armando Giuliano at Cedars-Sinai pioneered sentinel lymph node biopsy in breast cancer and led the landmark ACOSOG Z0011 trial demonstrating that axillary lymph node dissection can be safely omitted in early breast cancer patients with limited sentinel node involvement. This practice-changing trial has spared hundreds of thousands of women annually from unnecessary axillary dissection and its associated morbidity. His work transformed axillary staging in breast cancer surgery.